StarLIMS to Acquire Lonza’s MODA Platform

Octane Medical Group to Acquire Lonza’s Personalized Medicine Business

March 4, 2026

Healthcare Services

Octane Medical Group entered into a definitive agreement to acquire Lonza’s Personalized Medicine business, including Lonza’s controlling stake in the Cocoon cell-therapy platform plus related intellectual property, workforce, and existing customer contracts. The transaction is expected to close by the end of Q1 2026, subject to customary closing conditions.

AstraZeneca Acquires Modella AI

January 15, 2026

AI & Machine Learning

AstraZeneca has acquired Modella AI, a Boston-based biomedical AI company, to integrate its multimodal foundation models and agentic AI platform into AstraZeneca's global oncology R&D organization. The deal expands an existing multi-year collaboration to accelerate clinical development, improve biomarker discovery, and drive data-driven decision-making across AstraZeneca's oncology pipeline; financial terms were not disclosed.

Turn/River Capital Acquires StarLIMS from Francisco Partners

January 13, 2026

Software

Turn/River Capital has acquired StarLIMS, a Hollywood, Florida–based laboratory informatics software provider, from Francisco Partners in a transaction valued at roughly $200 million. Turn/River plans to scale StarLIMS’ product and go-to-market capabilities — including AI integration — while CEO Trey Cook remains in place as Francisco Partners fully exits the investment.

Matrix One Acquires Simploud to Add QMS and LIMS Capabilities

January 6, 2026

Software

Matrix One, a life sciences software provider backed by Lauxera Capital Partners, has acquired Simploud, a cloud-based maker of Quality Management System (QMS) and Laboratory Information Management System (LIMS) software. Simploud's products will be integrated into Matrix One's portfolio as Matrix QMS and Matrix LIMS to broaden the company's compliance and laboratory software offering for regulated life sciences and MedTech customers.

STARLIMS Acquires Labstep

August 22, 2023

Cloud & SaaS

STARLIMS has acquired Labstep, integrating Labstep’s cloud-based Electronic Laboratory Notebook (ELN) into STARLIMS’ enterprise informatics suite to support customers from R&D through product commercialization. The acquisition expands STARLIMS’ R&D capabilities and adds a modern, user-friendly ELN used by universities and companies worldwide.

Zymergen Acquires Lodo Therapeutics

May 28, 2021

Biotechnology

Zymergen Inc. acquired Lodo Therapeutics Corporation from Accelerator Life Science Partners (ALSP), integrating Lodo’s metagenomic natural‑product discovery platform into Zymergen’s technology stack. ALSP had been an investor and operator of Lodo following a $17 million Series A and a collaboration with Genentech; the financial terms of the deal were not disclosed by ALSP in its announcement.